The purpose of this study is to examine the physiological characteristics and
anti-diabetic effects of
Pediococcus pentosaceus
KI62. The
α-amylase and α-glucosidase inhibitory activity of
P.
pentosaceus
KI62 was 94.86±3.30% and
98.59±0.52%, respectively. In MRS broth containing 3%
maltodextrin inoculated by
P. pentosaceus
KI62, the amounts of
short chain fatty acids (SCFA) were propionic acid 18.05±1.85 mg/kg,
acetic acid 1.12±0.07 g/100 mL, and butyric acid 2.19±0.061 g/kg,
and those of medium chain fatty acids (MCFA) were C8 0.262±0.031 mg/kg,
C10 0.279±0.021 mg/kg, and C12 0.203±0.009 mg/kg. Compared to
sixteen antibiotics,
P. pentosaceus
KI62 had the highest
sensitivity to penicillin-G and rifampicin, as well as the highest resistance to
vancomycin and ampicillin. The strain also showed higher leucine arylamidase and
valine arylamidase activities than other enzyme activities, but it did not
produce β-glucuronidase which is carcinogenic enzymes. The survival rate
of
P. pentosaceus
KI62 in 0.3% bile was 91.67%.
Moreover, the strain showed a 98.63% survival rate in pH 2.0.
P.
pentosaceus
KI62 exhibits resistance to
Escherichia
coli
,
Salmonella
Typhimurium,
Listeria
monocytogenes
, and
Staphylococcus aureus
at rates
of 29.41%, 38.10%, 51.72%, and 50.47%, respectively.
P. pentosaceus
(23.31%) showed a similar adhesion
ability to
L. rhamnosus
GG, the positive control
(24.49%). These results show that
P. pentosaceus
KI62
has possibility as a probiotic with anti-diabetic effects.